Arch Biopartners (FRA:8HA) Total Assets: €0.29 Mil (As of Mar. 2026)


FRA:8HA Arch Biopartners Inc FRA:8HA
8 GF Score
Price €0.50
! 4 Warning Signs
View Full Analysis

What is Arch Biopartners Total Assets?

Arch Biopartners FRA:8HA -15.27% 8 Total Assets is €0.29 Mil as of Mar. 2026. GuruFocus rates FRA:8HA with a GF Score™ of 8/100. The stock has 4 warning signs investors should review.

Arch Biopartners's Total Assets for the quarter that ended in Mar. 2026 was €0.29 Mil.

During the past 12 months, Arch Biopartners's average Total Assets Growth Rate was -95.20% per year. During the past 3 years, the average Total Assets Growth Rate was -3.90% per year. During the past 5 years, the average Total Assets Growth Rate was -1.90% per year. During the past 10 years, the average Total Assets Growth Rate was 29.00% per year.

During the past 13 years, Arch Biopartners's highest 3-Year average Total Assets Growth Rate was 172.30%. The lowest was -81.50%. And the median was -3.70%.

Total Assets is connected with ROA %. Arch Biopartners's annualized ROA % for the quarter that ended in Mar. 2026 was -854.72%. Total Assets is also linked to Revenue through Asset Turnover. Arch Biopartners's Asset Turnover for the quarter that ended in Mar. 2026 was 0.00.

Arch Biopartners  (FRA:8HA) Total Assets Explanation

Total Assets is connected with ROA %.

Arch Biopartners's annualized ROA % for the quarter that ended in Mar. 2026 is

ROA %=Net Income (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=-1.312/( (0.015+0.292)/ 2 )
=-1.312/0.1535
=-854.72 %

Note: The Net Income data used here is four times the quarterly (Mar. 2026) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Arch Biopartners's Asset Turnover for the quarter that ended in Mar. 2026 is

Asset Turnover
=Revenue (Q: Mar. 2026 )/( (Total Assets (Q: Dec. 2025 )+Total Assets (Q: Mar. 2026 ))/ count )
=0/( (0.015+0.292)/ 2 )
=0/0.1535
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Arch Biopartners Total Assets Related Terms

Arch Biopartners Total Assets Historical Data

* Premium members only.

The historical data trend for Arch Biopartners's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arch Biopartners Total Assets Chart

Arch Biopartners Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.79 0.47 0.81 0.62 0.07

Arch Biopartners Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.35 0.17 0.07 0.02 0.29
FRA:8HA
8GF Score
Arch Biopartners Inc FRA:8HA
Total Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Arch Biopartners Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Arch Biopartners's Total Assets for the fiscal year that ended in Sep. 2025 is calculated as

Total Assets=Total Equity (A: Sep. 2025 )+Total Liabilities (A: Sep. 2025 )
=-2.391+2.455
=0.06

Arch Biopartners's Total Assets for the quarter that ended in Mar. 2026 is calculated as

Total Assets=Total Equity (Q: Mar. 2026 )+Total Liabilities (Q: Mar. 2026 )
=-2.297+2.589
=0.29

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Assets →
What does a Total Assets of €0.29 Mil mean?
Arch Biopartners (FRA:8HA) has a Total Assets of €0.29 Mil as of Mar. 2026. The total amount of assets as recorded on a company's balance sheet. View historical data on Arch Biopartners and its competitors.
Is Arch Biopartners' Total Assets too high?
Arch Biopartners' current Total Assets is €0.29 Mil. Overall, Arch Biopartners has a GF Score™ of 8/100, reflecting its overall financial health beyond just this single metric.
How does Arch Biopartners' Total Assets compare to VRTX and REGN?
Arch Biopartners' Total Assets of €0.29 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Assets for a Biotechnology company?
A good Total Assets depends on the Biotechnology industry context. However, Total Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Assets mean?
A high Total Assets can signal that a stock is expensive relative to its fundamentals. The total amount of assets as recorded on a company's balance sheet. View historical data on Arch Biopartners and its competitors. Arch Biopartners's current Total Assets is €0.29 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arch Biopartners stock overvalued right now?
Arch Biopartners (FRA:8HA) has a current Total Assets of €0.29 Mil. The current Total Assets is €0.29 Mil. Arch Biopartners' overall GF Score™ is 8/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Assets calculated?
Total Assets is calculated from a company's financial statements. For Arch Biopartners (FRA:8HA), the current Total Assets is €0.29 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Arch Biopartners Business Description

Other Exchanges ACHFF:USAARCH:Canada
Address 545 King Street West, Toronto, ON, CAN, M5V 1M1
Arch Biopartners Inc is a developer of a therapeutic pipeline designed to address acute kidney injury (AKI) and chronic kidney disease (CKD) by targeting inflammation- and toxin-related kidney damage. The group offers mechanism-based treatments, enabling patients suffering from both acute and chronic kidney conditions to benefit from novel, targeted therapies that address unmet medical needs in kidney care.
8GF Score

Get the complete analysis for FRA:8HA

Total Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.50
Price